ISRG

$432.013.73%-16.75

Dopo l'orario di chiusura: 432.30+0.29 +0.07%

Intuitive Surgical Inc (ISRG)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$448.76

Aprire:

$453.60

Volume 24 ore:

3,221,785

Volume relativo:

1.14

Capitalizzazione di mercato:

$152.62B

Reddito:

$11.03B

Utile/perdita netta:

$3.16B

Rapporto P/E:

49.51

EPS:

$8.73

Flusso di cassa netto:

$3.22B

1W Prestazione:

-4.48%

1M Prestazione:

+6.24%

6M Prestazione:

-5.59%

1Y Prestazione:

-18.49%

Intervallo 1D:

$431.19$453.60

Intervallo di 1 settimana:

$431.19$458.88

Portata 52W:

$328.57$603.88

Profilo aziendale di Intuitive Surgical Inc (ISRG)

Nome

Intuitive Surgical Inc

Settore

Healthcare

Industria

Medical Instruments & Supplies

Telefono

(408) 523-2100

Indirizzo

1020 KIFER ROAD, SUNNYVALE, USA

Dipendente

17,021

@IntuitiveSurg

Prossima data di guadagno

null

Ultimi documenti SEC

SEC

Discussioni di ISRG su X

Confronta ISRG con BDX, ALC, RMD, WST

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ISRG Intuitive Surgical Inc	$432.01	$152.62B	$11.03B	$3.16B	$3.22B	$8.73
BDX Becton Dickinson Co	$197.88	$53.90B	$21.37B	$1.41B	$3.07B	$3.94
ALC Alcon Inc	$71.45	$34.54B	$10.63B	$819.00M	$1.59B	$1.66
RMD Resmed Inc	$229.94	$32.34B	$5.54B	$1.52B	$1.74B	$10.37
WST West Pharmaceutical Services Inc	$412.62	$28.79B	$3.22B	$542.70M	$458.00M	$7.48

Intuitive Surgical Inc Azioni (ISRG) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-10-21	Aggiornamento	Erste Group	Hold → Buy
2026-10-07	Iniziato	Barclays	Overweight
2026-08-12	Aggiornamento	Oppenheimer	Perform → Outperform
2026-07-30	Downgrade	HSBC Securities	Buy → Hold
2026-07-28	Iniziato	UBS	Buy
2026-07-09	Iniziato	BMO Capital Markets	Outperform
2026-03-11	Aggiornamento	Citigroup	Neutral → Buy
2026-01-27	Iniziato	TD Cowen	Buy
2025-12-11	Downgrade	Citigroup	Buy → Neutral
2025-07-23	Downgrade	Erste Group	Buy → Hold
2025-06-09	Downgrade	Deutsche Bank	Hold → Sell
2025-06-05	Aggiornamento	Erste Group	Hold → Buy
2024-12-02	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2024-08-02	Aggiornamento	Redburn Atlantic	Neutral → Buy
2024-07-10	Reiterato	Citigroup	Buy
2024-05-30	Iniziato	Goldman	Buy
2023-11-17	Iniziato	HSBC Securities	Buy
2023-07-19	Iniziato	Robert W. Baird	Outperform
2023-04-19	Reiterato	BTIG Research	Buy
2023-04-19	Reiterato	BofA Securities	Buy
2023-04-19	Reiterato	Citigroup	Buy
2023-04-19	Reiterato	Evercore ISI	In-line
2023-04-19	Reiterato	JP Morgan	Overweight
2023-04-19	Reiterato	Morgan Stanley	Equal-Weight
2023-04-19	Reiterato	RBC Capital Mkts	Outperform
2023-04-19	Reiterato	Raymond James	Outperform
2023-04-19	Reiterato	Stifel	Buy
2023-04-19	Reiterato	Truist	Buy
2023-04-19	Reiterato	Wells Fargo	Overweight
2023-03-29	Iniziato	UBS	Neutral
2023-03-23	Iniziato	William Blair	Outperform
2022-10-18	Iniziato	Barclays	Overweight
2022-10-13	Iniziato	Mizuho	Neutral
2022-10-12	Iniziato	Jefferies	Hold
2022-04-13	Iniziato	Truist	Buy
2022-04-06	Iniziato	Wolfe Research	Peer Perform
2022-03-25	Iniziato	RBC Capital Mkts	Outperform
2022-03-02	Resumed	BofA Securities	Buy
2022-02-02	Aggiornamento	UBS	Neutral → Buy
2022-01-31	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-01-25	Downgrade	Redburn	Buy → Neutral
2022-01-21	Reiterato	BTIG Research	Buy
2022-01-21	Aggiornamento	Citigroup	Neutral → Buy
2022-01-21	Reiterato	Deutsche Bank	Hold
2022-01-21	Reiterato	Evercore ISI	In-line
2022-01-21	Reiterato	Morgan Stanley	Equal-Weight
2022-01-21	Reiterato	Piper Sandler	Neutral
2022-01-21	Reiterato	Raymond James	Outperform
2022-01-21	Reiterato	Robert W. Baird	Outperform
2022-01-21	Reiterato	Stifel	Buy
2022-01-21	Reiterato	UBS	Neutral
2022-01-21	Reiterato	Wells Fargo	Overweight
2022-01-10	Aggiornamento	BTIG Research	Neutral → Buy
2021-10-01	Downgrade	Citigroup	Buy → Neutral
2021-07-21	Reiterato	BofA Securities	Neutral
2021-07-21	Reiterato	Citigroup	Buy
2021-07-21	Reiterato	JP Morgan	Overweight
2021-07-21	Reiterato	Morgan Stanley	Equal-Weight
2021-07-21	Reiterato	Piper Sandler	Neutral
2021-07-21	Reiterato	SVB Leerink	Mkt Perform
2021-07-21	Reiterato	Stifel	Buy
2021-07-21	Reiterato	UBS	Neutral
2021-07-21	Reiterato	Wells Fargo	Overweight
2021-07-14	Reiterato	Goldman	Buy
2021-06-01	Aggiornamento	Evercore ISI	Underperform → In-line
2021-04-21	Aggiornamento	Oppenheimer	Underperform → Perform
2021-04-21	Aggiornamento	Robert W. Baird	Neutral → Outperform
2021-04-01	Iniziato	Citigroup	Buy
2020-12-15	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-09-28	Iniziato	Argus	Buy
2020-09-11	Iniziato	Wolfe Research	Outperform
2020-09-08	Downgrade	BofA Securities	Buy → Neutral
2020-09-02	Iniziato	Robert W. Baird	Neutral
2020-07-20	Reiterato	Bernstein	Outperform
2020-04-28	Downgrade	Piper Sandler	Overweight → Neutral
2020-04-17	Downgrade	CFRA	Hold → Sell
2020-04-17	Downgrade	SVB Leerink	Outperform → Mkt Perform
2020-04-09	Downgrade	Evercore ISI	In-line → Underperform
2020-04-01	Downgrade	Oppenheimer	Perform → Underperform
2020-01-27	Downgrade	Deutsche Bank	Buy → Hold
2019-12-12	Reiterato	Wells Fargo	Outperform
2019-11-21	Iniziato	Oppenheimer	Perform
2019-07-19	Reiterato	Canaccord Genuity	Buy
2019-04-22	Reiterato	Canaccord Genuity	Buy
2019-04-02	Iniziato	Deutsche Bank	Buy
2018-10-31	Reiterato	Piper Jaffray	Overweight
2018-10-19	Aggiornamento	Canaccord Genuity	Hold → Buy

Intuitive Surgical Inc Azioni (ISRG) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Intuitive Surgical Inc Azioni (ISRG) insider trading

Brosius MarkOct 28 '26
EVP & Chief Mfg and Supply Cha
Transazione
Sale
Costo
$441.60
#Azioni
61
Valore ($)
26,938
#Azioni Totale
581
Brosius MarkOct 27 '26
EVP & Chief Mfg and Supply Cha
Transazione
Sale
Costo
$451.63
#Azioni
61
Valore ($)
27,549
#Azioni Totale
642
Brosius MarkOct 26 '26
EVP & Chief Mfg and Supply Cha
Transazione
Sale
Costo
$451.75
#Azioni
61
Valore ($)
27,557
#Azioni Totale
703
PATRICIA WADORSOct 23 '26
Officer
Transazione
Proposed Sale
Costo
$443.85
#Azioni
1,078
Valore ($)
478,470
#Azioni Totale
0
BARRATT CRAIG HOct 23 '26
Director
Transazione
Sale
Costo
$443.80
#Azioni
1,150
Valore ($)
510,370
#Azioni Totale
0
Widman FredrikOct 23 '26
VP Corporate Controller
Transazione
Option Exercise
Costo
$229.14
#Azioni
4,047
Valore ($)
927,345
#Azioni Totale
5,073
Widman FredrikOct 23 '26
VP Corporate Controller
Transazione
Sale
Costo
$453.21
#Azioni
4,047
Valore ($)
1,834,124
#Azioni Totale
1,026
WADORS PATRICIA LOct 23 '26
SVP Chief Human Resources Offi
Transazione
Sale
Costo
$443.80
#Azioni
1,078
Valore ($)
478,416
#Azioni Totale
0
GUTHART GARY SOct 23 '26
Director
Transazione
Sale
Costo
$451.61
#Azioni
20,095
Valore ($)
9,075,137
#Azioni Totale
1,204,530
FREDRIK WIDMANOct 23 '26
Officer
Transazione
Proposed Sale
Costo
$443.85
#Azioni
5,136
Valore ($)
2,279,614
#Azioni Totale
0

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Brosius Mark	EVP & Chief Mfg and Supply Cha	Oct 28 '26	Sale	$441.60	61	26,938	581
Brosius Mark	EVP & Chief Mfg and Supply Cha	Oct 27 '26	Sale	$451.63	61	27,549	642
Brosius Mark	EVP & Chief Mfg and Supply Cha	Oct 26 '26	Sale	$451.75	61	27,557	703
PATRICIA WADORS	Officer	Oct 23 '26	Proposed Sale	$443.85	1,078	478,470	0
BARRATT CRAIG H	Director	Oct 23 '26	Sale	$443.80	1,150	510,370	0
Widman Fredrik	VP Corporate Controller	Oct 23 '26	Option Exercise	$229.14	4,047	927,345	5,073
Widman Fredrik	VP Corporate Controller	Oct 23 '26	Sale	$453.21	4,047	1,834,124	1,026
WADORS PATRICIA L	SVP Chief Human Resources Offi	Oct 23 '26	Sale	$443.80	1,078	478,416	0
GUTHART GARY S	Director	Oct 23 '26	Sale	$451.61	20,095	9,075,137	1,204,530
FREDRIK WIDMAN	Officer	Oct 23 '26	Proposed Sale	$443.85	5,136	2,279,614	0

Intuitive Surgical Inc Borsa (ISRG) Ultime notizie

Oct 30, 2026

DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/Y - Zacks Investment Research

Oct 30, 2026

RMD Stock Up on Q1 Earnings and Revenue Beat, Gross Margin Climbs - Zacks Investment Research

Oct 30, 2026

Oct 29, 2026